C. P. Dahl

Publications by Year

Research Areas

Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac Fibrosis and Remodeling, Gut microbiota and health, Adipose Tissue and Metabolism

Most-Cited Works

• → Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure(2014)468 cited
• → Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure(2009)293 cited
• → Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation(2016)162 cited
• → Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis(2010)124 cited
• → Inhibition of phosphodiesterase‐3 by levosimendan is sufficient to account for its inotropic effect in failing human heart(2014)73 cited
• → Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality(2011)50 cited
• → The cardiokine secreted Frizzled‐related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure(2013)45 cited
• → Ustekinumab in the Treatment of Refractory Chronic Cutaneous Lupus Erythematosus: A Case Report(2013)42 cited
• → Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis(2011)31 cited
• → 5‐HT₄‐elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles(2008)28 cited